InsidersTradesSigma
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Explore the complete record of transactions filed by Young James Emmett. Insider active across 1 company, notably TriSalus Life Sciences, Inc.. In total, 4 disclosures have been published. Breakdown: 1 buy · 0 sell. Total volume traded: €33k. History available since 27 January 2025. The latest transaction was filed on 19 May 2025 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations
Young James Emmett is a declarant linked to TriSalus Life Sciences, Inc., where he is Chief Financial Officer. Across 4 filings in total, the 4 sampled filings cover the period from 2025-01-29 to 2025-05-21, with buys of EUR 32682 and sells of EUR 0; the modal transaction nature is Attribution.